Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.
复制标题
DOI：
10.1186/s13722-023-00417-7
复制
发表时间：
2023-10-17
影响因子：
3.7
通讯作者：
Schwartz, Robert P.
中科院分区：
文献类型：
--
作者：
Mitchell, Shannon Gwin;Jester, Julia;Gryczynski, Jan;Whitter, Melanie;Fuller, Douglas;Halsted, Caroline;Schwartz, Robert P.
在2019冠状病毒病大流行期间，美国临时修订了美沙酮治疗阿片类药物使用障碍的联邦法规，以减少诊所拥挤并促进获得治疗。作为一项研究的一部分，寻求在没有常规咨询的情况下实施临时美沙酮，以加速入院延迟的阿片类药物治疗项目的治疗可及性，通过Zoom对6个OTPs及其负责监督OTPs联邦法规遵从性的州阿片类药物治疗机构（SOTAs; N = 5）的参与工作人员（N = 11）进行了半结构化定性访谈。与会者讨论了他们对各州otp应对大流行的看法，以及与covid相关的监管灵活性对工作人员、现有患者和新项目申请人的影响。访谈录音、转录，并使用ATLAS.ti进行内容分析。所有sota都要求全面豁免，并支持使用远程保健进行咨询。参与者指出，这些变化对已建立的患者比计划申请人更有利。已建立的病人能够获得更多的带回家和参加远程个人咨询。资源有限的患者有更大的困难或无法获得远程咨询。由于没有免除入学体检要求，因此通过远程保健入学的便利并未扩展到新方案申请人。sota和OTP提供商对2019冠状病毒病大流行期间美沙酮实践变化的经验反映，为SAMHSA对其OTP法规的拟议修订提供了见解。临床试验注册：Clinicaltrials.gov # NCT04188977。
During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment. As part of a study seeking to implement interim methadone without routine counseling to hasten treatment access in Opioid Treatment Programs with admission delays, semi-structured qualitative interviews were conducted via Zoom with participating staff (N = 11) in six OTPs and their State Opioid Treatment Authorities (SOTAs; N = 5) responsible for overseeing the OTPs’ federal regulatory compliance. Participants discussed their views on the response of OTPs in their states to the pandemic and the impact of the COVID-related regulatory flexibilities on staff, established patients, and new program applicants. Interviews were audio recorded, transcribed, and a content analysis was conducted using ATLAS.ti. All SOTAs requested the blanket take-home exemption and supported the use of telehealth for counseling. Participants noted that these changes were more beneficial for established patients than program applicants. Established patients were able to obtain a greater number of take-homes and attend individual counseling remotely. Patients with limited resources had greater difficulty or were unable to access remote counseling. The convenience of intake through telehealth did not extend to new program applicants because the admission physical exam requirement was not waived. The experienced reflections of SOTAs and OTP providers on methadone practice changes during the COVID-19 pandemic offer insights on SAMHSA’s proposed revisions to its OTP regulations. Trial registration Clinicaltrials.gov # NCT04188977.
登录
查看更多内容
影响因子：
2.8
作者：
Ritchie MJ;Parker LE;Edlund CN;Kirchner JE
通讯作者：
Kirchner JE
影响因子：
3.9
作者：
Brothers, Sarah;Viera, Adam;Heimer, Robert
通讯作者：
Heimer, Robert
影响因子：
3.2
作者：
Hsieh, HF;Shannon, SE
通讯作者：
Shannon, SE
影响因子：
6
作者：
Krawczyk, Noa;Mojtabai, Ramin;Saloner, Brendan
通讯作者：
Saloner, Brendan
DOI：
10.1080/00952990.2021.1903023
发表时间：
2021-07-04
期刊：
The American journal of drug and alcohol abuse
影响因子：
--
作者：
Andraka-Christou B;Bouskill K;Haffajee RL;Randall-Kosich O;Golan M;Totaram R;Gordon AJ;Stein BD
通讯作者：
Stein BD